13 employees
Evrys Bio is a pharmaceutical company for providing health care solutions to defend against the virus.
2012
Evrys Bio raised undisclosed on December 1, 2017
Investors: Keiretsu Capital
Evrys Bio raised undisclosed on June 1, 2016
Investors: Mid Atlantic Bio Angels